Literature DB >> 17805218

Akathisia: problem of history or concern of today.

Naveed Iqbal1, Tim Lambert, Prakash Masand.   

Abstract

Akathisia is a neurological side effect of antipsychotic medications, which are used to treat various psychiatric disorders, and is characterized by physical restlessness and a subjective urge to move. Although side effects, such as akathisia, dystonia, and dyskinesia, are common for conventional medications, these effects occur in reduced frequency with the use of new-generation antipsychotics. Despite a lowered incidence profile, akathisia and similar conditions continue to affect patients. Neuroleptic-induced akathisia can present as fidgety movements while seated, rocking in place while standing, pacing, or the inability to sit or stand still for an extended period of time as well as the overwhelming urge to move, which can cause severe distress and an increased risk of suicide for affected patients. First-line treatment of akathisia includes benzodiazepines or beta-blockers for patients who do not have symptoms of Parkinson's disease and anticholinergics for patients with Parkinson's symptoms. Clinicians should ensure that an accurate diagnosis of akathisia is made and target symptoms are decreasing due to treatment, which does not negatively affect the mental health of the patient. This expert roundtable supplement will address the diagnosis, pathophysiology, phenomenology, classification, and history of akathisia as well as provide screening tools and treatment options for the condition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17805218     DOI: 10.1017/s1092852900026201

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  11 in total

1.  Safety and tolerability of antipsychotic polypharmacy.

Authors:  Juan A Gallego; Jimmi Nielsen; Marc De Hert; John M Kane; Christoph U Correll
Journal:  Expert Opin Drug Saf       Date:  2012-05-08       Impact factor: 4.250

2.  Akathisia: a life-threatening side effect of a common medication.

Authors:  Hui M Cheng; Jae H Park; David Hernstadt
Journal:  BMJ Case Rep       Date:  2013-05-21

Review 3.  The Importance of Medicinal Chemistry Knowledge in the Clinical Pharmacist's Education.

Authors:  João Paulo S Fernandes
Journal:  Am J Pharm Educ       Date:  2018-03       Impact factor: 2.047

4.  Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptors.

Authors:  Tsutomu Furuse; Kenji Hashimoto
Journal:  Ann Gen Psychiatry       Date:  2010-03-06       Impact factor: 3.455

5.  Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five cases.

Authors:  Tsutomu Furuse; Kenji Hashimoto
Journal:  Ann Gen Psychiatry       Date:  2010-04-24       Impact factor: 3.455

6.  Delayed-onset akathisia due to amisulpride.

Authors:  Murad Atmaca; Sevda Korkmaz
Journal:  Indian J Pharmacol       Date:  2011-07       Impact factor: 1.200

Review 7.  The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis.

Authors:  Jennifer E Thomas; Joshua Caballero; Catherine A Harrington
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

Review 8.  Revisiting Antipsychotic-induced Akathisia: Current Issues and Prospective Challenges.

Authors:  Haitham Salem; Caesa Nagpal; Teresa Pigott; Antonio Lucio Teixeira
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

9.  Effect of Vitamin B6 Versus Propranolol on Antipsychotic-Induced Akathisia: A pilot Comparative Double-blind Study.

Authors:  Narges Shams-Alizadeh; Hamid Bakhshayesh; Farzin Rezaei; Ebrahim Ghaderi; Nasim Shams-Alizadeh; Kambiz Hassanzadeh
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

10.  Measurement of Motivation States for Physical Activity and Sedentary Behavior: Development and Validation of the CRAVE Scale.

Authors:  Matthew A Stults-Kolehmainen; Miguel Blacutt; Nia Fogelman; Todd A Gilson; Philip R Stanforth; Amanda L Divin; John B Bartholomew; Alberto Filgueiras; Paul C McKee; Garrett I Ash; Joseph T Ciccolo; Line Brotnow Decker; Susannah L Williamson; Rajita Sinha
Journal:  Front Psychol       Date:  2021-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.